B&R Technology Merger (BRTM) vs Drugs Made In America Acquisition II (DMII)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Drugs Made In America Acquisition II is the larger company by market cap ($649.1 million vs $478.7 million), about 1.4 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BRTM | DMII |
|---|---|---|
| Share price | $9.79 | $10.19 |
| Market cap | $478.69M | $649.10M |
| 1-day change | 0.00% | 0.00% |
| P/E ratio (TTM) | — | 33.97 |
| EPS (TTM) | — | $0.30 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $10.25 | $10.33 |
| 52-week low | $9.78 | $9.86 |
| Distance from 52-week high | -4.49% | -1.36% |
| Average volume | 69.05K | 57.23K |
| Shares outstanding | 38.06M | 63.70M |
| Sector | Finance | Finance |
| Industry | Blank Checks | Blank Checks |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About B&R Technology Merger
BRTM stock →B&R Technology Merger Corp. is a blank check company.
Finance · Blank Checks
About Drugs Made In America Acquisition II
DMII stock →Drugs Made In America Acquisition II Corp. does not have significant operations.
Finance · Blank Checks
BRTM vs DMII FAQ
Which is bigger, B&R Technology Merger or Drugs Made In America Acquisition II?
Drugs Made In America Acquisition II (DMII) is larger, with a market capitalization of $649.10M compared with $478.69M for B&R Technology Merger (BRTM).
Are B&R Technology Merger and Drugs Made In America Acquisition II in the same industry?
Yes. Both are classified in the Blank Checks industry within the Finance sector.